Neogenomics Inc
NEO· Nasdaq
NEONeogenomics Inc
Filed Aug 2, 2013 · 10-Q · 33 days after period end · 0001193125-13-316554
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Net Income | $273.00K | $551.00K | -$293.00K | -$978.00K |
| EPS Diluted | $0.01 | $0.01 | -$0.01 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Jun 30, 2013 · filed Aug 2, 2013 · 33 d after period end
